Small Cap Stocks To Buy
Investment News Show To Feature
Small Cap Medical Stocks to Buy
Money Info Show Airs
10 AM to 11 AM EDT
Use this Link To Watch The Show:
Be On The Air With Us
Call In Your Questions
The July 15th Money Info Show will feature a live interview with
Neil Lyons,CFO of Cleveland BioLabs, Inc.
(NASDAQ Stock Symbol: CBLI).
Corporate Site: cbiolabs.com
Developing and commercializing
Innovative Drugs To
and orphan diseases and
protect healthy tissues.
Cleveland BioLabs, Inc. is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need.
The company’s lead product candidates are Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment and Curaxin CBL0137, our lead oncology product candidate.
CBL0137 is under development by Incuron, LLC, a Russian Federation based joint venture founded in 2010 between Russian Closed Mutual Venture Fund “Bioprocess Capital Ventures,” and Cleveland BioLabs.
Cleveland BioLabs, Inc. conducts business in the United States and in the Russian Federation through its wholly and majority owned operating subsidiaries.
The company maintains strategicrelationships with the Cleveland Clinic, Roswell Park Cancer Institute, and the Children’s Cancer Institute Australia for Medical Research.
To learn more about Cleveland BioLabs, Inc.
visit the Company’s website at CBIOLabs.com.
To learn more about Incuron, LLC
visit the company’s website at Incuron.com.
See more at Yahoo Finance Small Cap Medical Stock News
About Neil Lyons, CPA — Chief Financial Officer
Mr. Lyons joined Cleveland BioLabs as Chief Financial Officer in 2011.
He has more than 30 years of experience in operations, finance, strategy, SEC compliance, information systems and corporate governance in both public and private companies.
Prior to joining the Company, Mr. Lyons served as Chief Financial Officer, Secretary and Treasurer of RegeneRx Biopharmaceuticals, Inc, where he led several financial transactions, influenced clinical/corporate strategy, identified and captured government grant opportunities, directed investor relations, developed financial models and implemented investment strategies and employee benefit programs.
Medical Stocks In The News
Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered Stock
(Marketwired – Jun 18, 2014) – Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it entered into a securities purchase agreement (the “Purchase Agreement”) with Dr. Mikhail Mogutov, Chairman of the Board of Directors of Incuron, LLC and Chairman of the Investment Committee and founder of Bioprocess Capital Ventures and one institutional investor (the “Investors”), to issue and sell in a private placement $3.5 million worth of the Company’s common stock, par value $.005 per share (the “Common Stock”),and warrants to purchase Common Stock.
Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, “This transaction deepens our strategic relationship with Dr. Mogutov. We appreciate his continued support of our science and development pipeline. These proceeds enable us to reduce the debt on our balance sheet by two-thirds, favorably impacting our cash runway.”
The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.
Money Info is hosted by Mike King and Charles Moskowitz.
Investment News Show